Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 17,968
-104 (-0.58%)
Jun 25, 2026, 3:29 PM IST
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 230.14 billion as of June 26, 2026. Its market cap has increased by 52.61% in one year.
Market Cap
230.14B
Enterprise Value
229.60B
Revenue
20.23B
Ranking
n/a
PE Ratio
63.22
Stock Price
17,968.00
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 230.14B, an increase of 68,569.13%. That is a compound annual growth rate of 29.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 230.14B | 18.09% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 412.27B |
| Ajanta Pharma | 406.60B |
| Gland Pharma | 378.64B |
| Emcure Pharmaceuticals | 344.41B |
| Wockhardt | 326.67B |
| Piramal Pharma | 224.26B |
| Eris Lifesciences | 202.45B |
| Cohance Lifesciences | 175.14B |